Back to 
Assenagon Asset Management S.A.
Assenagon Asset Management S.A.
ADMA
Showing 5 of 21 quarters
Position history for Assenagon Asset Management S.A.'s holdings in ADMA BIOLOGICS INC
No. Assenagon Asset Management exited its ADMA (Adma Biologics) position in Q3 2025. Its Q2 2025 13F listed 12,050 shares worth $219,431. Assenagon Asset Management first reported ADMA in Q2 2020 and held it in 19 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$69.5M
Total Shares Change
-3.5M
Quarter-by-Quarter History